A study to confirm the efficacy and safety of different dupilumab dose regimens in adults with atopic dermatitis (AD)

Update Il y a 4 ans
Reference: EUCTR2014-003384-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to assess the ability of different dupilumab dose regimens, administered as monotherapy, to maintain the treatment response achieved after 16 weeks of initial treatment with dupilumab monotherapy compared to placebo.


Inclusion criteria

  • Atopic dermatitis